Acute necrotizing eosinophilic myocarditis presenting with cardiogenic shock after mRNA booster dose for COVID-19: Case report and review of literature.
作者信息
Abete Raffaele, Valastro Pietro, Iacovoni Attilio, Vittori Claudia, Arbustini Eloisa, Pellicioli Federica, Schiavo Alessandra, Grazioli Lorenzo Stephan Cesare, Lorini Ferdinando Luca, Senni Michele
机构信息
Dipartimento Cardiovascolare, ASST Papa Giovanni XXIII, Bergamo, Italy.
Dipartimento Emergenza Urgenza e Area Critica, ASST Papa Giovanni XXIII, Bergamo, Italy.
出版信息
J Cardiol Cases. 2022 Oct 11;27(2):52-55. doi: 10.1016/j.jccase.2022.10.001. eCollection 2023 Feb.
Abstract
摘要
相似文献
1
Acute necrotizing eosinophilic myocarditis presenting with cardiogenic shock after mRNA booster dose for COVID-19: Case report and review of literature.新冠病毒病mRNA加强剂量疫苗接种后出现心源性休克的急性坏死性嗜酸性粒细胞性心肌炎：病例报告及文献综述
J Cardiol Cases. 2022 Oct 11;27(2):52-55. doi: 10.1016/j.jccase.2022.10.001. eCollection 2023 Feb.
2
Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory support.COVID-19 疫苗接种后暴发性坏死性嗜酸性心肌炎在机械循环支持下得以存活。
ESC Heart Fail. 2022 Aug;9(4):2732-2737. doi: 10.1002/ehf2.13962. Epub 2022 May 26.
3
Significance of troponin I level as a marker of disease activity in the management of acute necrotizing eosinophilic myocarditis with normal peripheral eosinophil count: a case report.肌钙蛋白I水平作为外周血嗜酸性粒细胞计数正常的急性坏死性嗜酸性粒细胞性心肌炎管理中疾病活动标志物的意义：一例报告
Eur Heart J Case Rep. 2018 Nov 26;2(4):yty139. doi: 10.1093/ehjcr/yty139. eCollection 2018 Dec.
4
Acute necrotizing eosinophilic myocarditis complicated by complete atrioventricular block promptly responded to glucocorticoid therapy.急性坏死性嗜酸性粒细胞性心肌炎合并完全性房室传导阻滞对糖皮质激素治疗迅速起效。
J Cardiol Cases. 2017 Apr 14;16(1):5-8. doi: 10.1016/j.jccase.2017.03.002. eCollection 2017 Jul.
5
A case of BNT162b2 COVID-19 vaccine-associated fulminant myocarditis in a very elderly woman.一名老年女性发生BNT162b2新冠疫苗相关暴发性心肌炎的病例。
Clin Case Rep. 2022 Sep 5;10(9):e6161. doi: 10.1002/ccr3.6161. eCollection 2022 Sep.
6
Acute necrotizing eosinophilic myocarditis successfully treated by high dose methylprednisolone.大剂量甲泼尼龙成功治疗急性坏死性嗜酸性粒细胞性心肌炎
Jpn Circ J. 2001 Oct;65(10):923-6. doi: 10.1253/jcj.65.923.
7
A Curious Case of Coronary Vasospasm with Cardiogenic Shock: Type 1 Kounis Syndrome Complicated by Eosinophilic Myocarditis.一例伴有心源性休克的冠状动脉痉挛罕见病例：1型库尼斯综合征合并嗜酸性粒细胞性心肌炎
Cureus. 2019 Apr 22;11(4):e4522. doi: 10.7759/cureus.4522.
8
Fulminant myocarditis after the first dose of mRNA-1273 vaccination in a patient with previous COVID-19: a case report.既往感染过新冠病毒的患者在接种第一剂mRNA-1273疫苗后发生暴发性心肌炎：一例病例报告
Eur Heart J Case Rep. 2022 Jul 8;6(7):ytac290. doi: 10.1093/ehjcr/ytac290. eCollection 2022 Jul.
9
A case of acute eosinophilic myopericarditis presenting with cardiogenic shock and normal peripheral eosinophil count.一例表现为心源性休克且外周血嗜酸性粒细胞计数正常的急性嗜酸性粒细胞性心肌心包炎病例。
Korean J Intern Med. 2006 Jun;21(2):136-40. doi: 10.3904/kjim.2006.21.2.136.
10
Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination.mRNA 疫苗接种 24 天后爆发性心肌炎。
Intern Med. 2022 Aug 1;61(15):2319-2325. doi: 10.2169/internalmedicine.9800-22. Epub 2022 May 31.
引用本文的文献
1
Eosinophilic Endomyocarditis After COVID-19 Infection in a Heart Transplant Recipient.一名心脏移植受者感染 COVID-19 后的嗜酸性粒细胞性心内膜炎
JACC Case Rep. 2024 Sep 18;29(18):102527. doi: 10.1016/j.jaccas.2024.102527.
2
Commentary on: "Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination" by C. Schwab et al.对C.施瓦布等人所著《基于尸检的抗SARS-CoV-2疫苗接种后心肌炎的组织病理学特征》的评论
Clin Res Cardiol. 2024 Feb;113(2):353-355. doi: 10.1007/s00392-023-02197-1. Epub 2023 Apr 25.
本文引用的文献
1
Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis.接种 COVID-19 疫苗和非 COVID-19 疫苗后的心肌炎：系统评价和荟萃分析。
Lancet Respir Med. 2022 Jul;10(7):679-688. doi: 10.1016/S2213-2600(22)00059-5. Epub 2022 Apr 11.
2
Hypersensitivity Myocarditis after COVID-19 mRNA Vaccination.新冠病毒mRNA疫苗接种后的超敏性心肌炎
J Clin Med. 2022 Mar 16;11(6):1660. doi: 10.3390/jcm11061660.
3
First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction.首例辉瑞-生物科技 mRNA COVID-19 疫苗（BNT162b2，Comirnaty）初始剂量后致命性暴发性嗜酸性粒细胞性心肌炎：一种极其罕见的特发性过敏反应。
J Clin Immunol. 2022 Apr;42(3):441-447. doi: 10.1007/s10875-021-01187-0. Epub 2022 Jan 3.
4
Myocarditis after Covid-19 mRNA Vaccination.新冠病毒mRNA疫苗接种后的心肌炎
N Engl J Med. 2021 Sep 30;385(14):1332-1334. doi: 10.1056/NEJMc2109975. Epub 2021 Aug 18.
5
The state of vaccine safety science: systematic reviews of the evidence.疫苗安全科学现状：证据的系统评价。
Lancet Infect Dis. 2020 May;20(5):e80-e89. doi: 10.1016/S1473-3099(20)30130-4. Epub 2020 Apr 9.
6
Eosinophilic Myocarditis: Classic Presentation of Elusive Disease.嗜酸性粒细胞性心肌炎：隐匿性疾病的典型表现。
Circ Cardiovasc Imaging. 2019 Sep;12(9):e009487. doi: 10.1161/CIRCIMAGING.119.009487. Epub 2019 Aug 27.
7
(A Critical Appraisal of) Classification of Hypereosinophilic Disorders.嗜酸性粒细胞增多性疾病的分类（批判性评估）
Front Med (Lausanne). 2017 Dec 5;4:216. doi: 10.3389/fmed.2017.00216. eCollection 2017.
8
Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes.嗜酸性粒细胞性心肌炎：特征、治疗和结局。
J Am Coll Cardiol. 2017 Nov 7;70(19):2363-2375. doi: 10.1016/j.jacc.2017.09.023.
9
Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis.嗜酸性粒细胞性心肌炎的当前诊断与治疗方面
Biomed Res Int. 2016;2016:2829583. doi: 10.1155/2016/2829583. Epub 2016 Jan 17.
10
Cardiovascular manifestations of hypereosinophilic syndromes.嗜酸性粒细胞增多综合征的心血管表现。
Immunol Allergy Clin North Am. 2007 Aug;27(3):457-75. doi: 10.1016/j.iac.2007.07.001.
Zotero 插件